Inhibition of oxidative stress delays senescence and augments functional capacity of endothelial progenitor cells.


Journal

Brain research
ISSN: 1872-6240
Titre abrégé: Brain Res
Pays: Netherlands
ID NLM: 0045503

Informations de publication

Date de publication:
15 07 2022
Historique:
received: 24 02 2022
revised: 01 04 2022
accepted: 19 04 2022
pubmed: 27 4 2022
medline: 18 5 2022
entrez: 26 4 2022
Statut: ppublish

Résumé

Ageing is characterised by a progressive loss of vascular endothelial function and integrity. Endothelial progenitor cells (EPCs) play an integral role in endothelial regeneration but are prone to age-dependent changes which may accelerate their senescence and diminish their availability and functionality. Considering these, we firstly investigated the quantity of circulating EPCs in older (73.3 ± 7.2 years) and younger (40.2 ± 14.3 years) healthy volunteers and showed sharp declines in the number of EPCs expressing stemness markers (CD34 + and/or CD133 + ) in older people. These coincided with the decreases in total anti-oxidant capacity (TAC) and concomitant increases in plasma levels of pro-inflammatory cytokine, TNF-α and anti-angiogenic factor, endostatin and thrombospondin-1. The subsequent experimental studies to scrutinise the effect of ageing on molecular and functional properties of outgrowth endothelial cells (OECs), the functional subtype of EPCs, showed that chronological ageing, mimicked by replicative senescence, profoundly impaired proliferation, migration, tubulogenesis, and blood-brain barrier (BBB)-forming capacity of these cells. Similar to those seen in the clinical observational studies, senescent OECs also manifested decreased TAC and increased pro-oxidant NADPH oxidase activity and endostatin level. Suppressing oxidative stress level using structurally and functionally distinct anti-oxidants, namely vitamin C or VAS2870, an NADPH oxidase inhibitor, delayed OEC senescence and restored their tubulogenic and BBB-forming capacities. In conclusion, the enhanced oxidative stress level that develops during physiological ageing may promote EPC senescence and evoke endothelial dysfunction. Effective control of oxidative stress using either compound somewhat delays both phenomena and augments EPC functionality.

Identifiants

pubmed: 35469846
pii: S0006-8993(22)00149-4
doi: 10.1016/j.brainres.2022.147925
pii:
doi:

Substances chimiques

Antioxidants 0
Endostatins 0
NADPH Oxidases EC 1.6.3.-

Banques de données

ClinicalTrials.gov
['NCT02980354']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

147925

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Rais Reskiawan A Kadir (R)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: rais.kadir@nottingham.ac.uk.

Mansour Alwjwaj (M)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: mansour.alwjwaj@nottingham.ac.uk.

Othman Ahmad Othman (O)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom.

Kamini Rakkar (K)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: kamini.rakkar2@nottingham.ac.uk.

Nikola Sprigg (N)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: nikola.sprigg@nottingham.ac.uk.

Philip M Bath (PM)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: philip.bath@nottingham.ac.uk.

Ulvi Bayraktutan (U)

Stroke, Academic Unit of Mental Health and Clinical Neuroscience, The University of Nottingham, United Kingdom. Electronic address: ulvi.bayraktutan@nottingham.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH